Tracleer

Bosentan is an endothelin receptor antagonist used to treat pulmonary arterial hypertension. This oral medication helps improve exercise capacity and symptoms in adults. It is prescribed under the brand name Tracleer. Suitable for long-term management of PAH in eligible patients.

Bosentan is primarily used to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the lungs. It helps reduce symptoms such as shortness of breath and fatigue by relaxing blood vessels in the lungs. This medication may also be used to slow the progression of PAH in adults. Patients often ask, 'What is bosentan used for?' as it targets a specific type of hypertension.

Bosentan works by blocking endothelin receptors, which helps dilate blood vessels in the lungs and improve blood flow. Patients may notice improved ability to perform daily activities and reduced breathlessness over time. The effects of bosentan are typically gradual, with noticeable benefits developing over weeks of consistent use.

Bosentan requires regular monitoring, including liver function tests, due to potential effects on the liver. It is not suitable for individuals with moderate to severe liver problems or those who are pregnant. Patients should discuss their full medical history with their healthcare provider before starting this medication. Avoid use if you have a known allergy to bosentan.

Bosentan can interact with other medications, including certain antibiotics, antifungals, and HIV treatments, which may increase its effects or side effects. Combining it with cyclosporine or glyburide is not recommended due to potential interactions. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using. Alcohol use may also affect how bosentan works.